Periportal necrosis and successful liver transplantation following Lamotrigine drug-induced liver injury in a child

BMJ Case Rep. 2023 Nov 24;16(11):e255787. doi: 10.1136/bcr-2023-255787.

Abstract

Lamotrigine is one of the most prescribed antiepileptics in children and a well-known cause of drug-induced liver injury (DILI). The typical presentation usually includes a drug rash with eosinophilia and systemic symptoms (DRESS syndrome). Cases are typically mild and self-limiting, requiring supportive care only. We report a severe Lamotrigine-induced DILI with a non-typical presentation with hyperammonaemia and rapid clinical deterioration. We present a literature review exploring contributing factors, transplant considerations and liver histology. Histology showed periportal necrosis, which is recognised as a pattern of DILI but has not been previously described with Lamotrigine. Our patient proceeded to transplant and is the first reported liver transplant for Lamotrigine DILI in a child. A directed and rapid diagnostic approach is crucial to avoid delays and rule out multisystemic metabolic and genetic conditions that preclude liver transplantation.

Keywords: Gastrointestinal system; Hepatitis other; Paediatrics; Paediatrics (drugs and medicines).

Publication types

  • Case Reports
  • Review

MeSH terms

  • Anticonvulsants / adverse effects
  • Chemical and Drug Induced Liver Injury* / complications
  • Chemical and Drug Induced Liver Injury* / etiology
  • Child
  • Drug Hypersensitivity Syndrome* / diagnosis
  • Drug Hypersensitivity Syndrome* / etiology
  • Humans
  • Lamotrigine / adverse effects
  • Liver Transplantation*
  • Necrosis / complications

Substances

  • Anticonvulsants
  • Lamotrigine